diminazene aceturate has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, AB; Malek, V; Sankrityayan, H; Sharma, N | 1 |
| Burrell, LM; Griggs, K; Patel, SK; Velkoska, E | 1 |
2 other study(ies) available for diminazene aceturate and Fibrosis
| Article | Year |
|---|---|
Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diminazene; Fibrosis; Inflammation; Kidney; Male; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System; Streptozocin; Telmisartan; Thiorphan | 2019 |
Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diminazene; Female; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 2016 |